SuperworthStandard Biotools shares outstanding LAB
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Jun 30, 2026
- 390.9M
- On a year earlier
- +2.7%
- more shares
Standard Biotools had 390.9M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 2.7% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 385.1M | +3% |
| FY2024 | 374.5M | +370% |
| FY2023 | 79.7M | +0% |
| FY2022 | 79.4M | +4% |
| FY2021 | 76.7M | +3% |
| FY2020 | 74.3M | +7% |
| FY2019 | 69.7M | +68% |
| FY2018 | 41.5M | +7% |
| FY2017 | 38.7M | +33% |
| FY2016 | 29.2M | +1% |
| FY2015 | 28.8M | +2% |
| FY2014 | 28.2M | +10% |
| FY2013 | 25.7M | +3% |
| FY2012 | 25M | +22% |
| FY2011 | 20.4M | +958% |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 390.9M | +3% | |
| Q1 FY26 | 388.2M | +3% | |
| Q4 FY25 | 385.1M | +3% | |
| Q3 FY25 | 382.6M | +3% | |
| Q2 FY25 | 380.5M | +2% | |
| Q1 FY25 | 378.2M | +29% | |
| Q4 FY24 | 374.5M | +370% | |
| Q3 FY24 | 371.5M | +369% | |
| Q2 FY24 | 372.3M | +373% | |
| Q1 FY24 | 294.1M | +272% | |
| Q4 FY23 | 79.7M | +0% | |
| Q3 FY23 | 79.2M | +0% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Standard Biotools
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.